DONATE

IBEC showcases its leadership in biomedical innovation at MWC26 with three disruptive projects

Last week, Barcelona played host to MWC26, the world’s premier technology and connectivity event. The Institute for Bioengineering of Catalonia was in attendance, showcasing some of its spin-offs and state-of-the-art biomedical technologies, including: Nanobots Therapeutics, Lumiris Spectral Solutions, and Drug4Sight.

BIST calls for reforms to turn scientific discoveries into European industry

The BIST Forum 2026 brought together scientists and representatives from academic, economic and social institutions to discuss how frontier research can help build Europe’s industries of the future. The event also announced the recipients of the BIST To the Mothers of Science and Ignite programmes.

IBEC secures competitive funding to drive forward validation testing for three innovative health projects

IBEC has been awarded three grants in response to the call for proposals from the Strategic Plan for Health Research and Innovation (PERIS). These projects aim to validate hyperspectral technology for improving assisted reproduction, using bioprinted cell spheroids to combat type 1 diabetes and developing light-activated drugs to restore vision in patients with retinal degeneration.

Bioengineering for precision medicine at the 18th IBEC Symposium

The 18th annual IBEC Symposium focused on ‘Bioengineering for Precision Medicine’, which is one of IBEC’s key areas of application. The event was attended by nearly 300 people, including local and international researchers. The multidisciplinary environment provided experts from other centres and the IBEC community with the opportunity to present their projects and exchange knowledge.

3Cat – TELENOTÍCIES MIGDIA | Graven tot el procés d’implantació d’un embrió en temps real

Un grupo de investigadores del Instituto de Bioingeniería de Cataluña han logrado grabar la implantación de un embrión humano en tiempo real. Lo han hecho in vitro recreando las condiciones del útero. Los resultados de la investigación servirán para mejorar la fertilidad. Declaraciones de Samuel Ojosnegros, investigador principal Instituto de Bioingeniería de Cataluña; Amélie Godeau, autora del estudio.